List view / Grid view

non-alcoholic fatty liver disease (NAFLD)

Filter the results

 

article

Screening In-Depth Focus 2020

26 May 2020 | By

Included in this in-depth focus are articles on how high-throughput screening can be used to identify lead compounds, using chemoinformatics as a map to guide drug discovery and a novel in vitro model to screen potential treatments for non-alcoholic fatty liver disease (NAFLD).